Tencent, Hillhouse, and Yunfeng Lead USD176m Series F for Chinese Medical SaaS Startup Taimei Technology
Source(s): DealStreetAsia
Tencent Holdings, Hillhouse’s VC arm GL Ventures, and Yunfeng Capital led a CNY1.2b (approximately USD176m) Series F for China-based medical SaaS startup Taimei Technology, with participation from Zheshang Venture Capital, Morningside Venture Capital, Matrix Partners China, SBCVC, Cowin Capital, Ivy Capital, Beijing Future Startup Fund Management, and Fanzhuo Capital. Read more